Jardiance® - HF
10 mg| Tablets
From April 1, 2023, the use of Jardiance® (empagliflozin) in patients with chronic heart failure regardless of ejection fraction (HFrEF, HFmrEF and HFpEF) is regularly reimbursed through the health insurance. Due to the extension of the reimbursement of Jardiance®(empagliflozin), the reimbursement scheme by TBR Nederland is lifted. The Pharmacy or patient can declare dispensations between the period March 3, 2022 to April 1, 2023 up to September 1, 2023 at the latest.
For a complete reimbursment overview of Jardiance® 10 mg, click here.
|Dose||Jardiance® 10 mg|
Jardiance®(empagliflozin) 10 mg was fully reimbursed from March 3, 2022 to April 1, 2023 through TBR Nederland. Issues that have taken place during this period can be submitted until September 1, 2023 at the latest.
1. Patients or their carer can claim the costs for Jardiance® 10 mg online or by post.
2. Pharmacists can only claim this medicine online, on behalf of the patient.
Patients can claim online and will receive their reimbursement within 5 working days.
Patients can claim by post and will receive their reimbursement within 15 working days.
Please mail the Claim Form and attachments to:
1180 LA Amstelveen
Quickly check the maximum contribution you have to pay for your medicine